Viral hemorrhagic fever in the tropics: Report from the task force on tropical diseases by the World Federation of Societies of Intensive and Critical Care Medicine

Journal of Critical Care

Volumn 42, Issue , 2017, Pages 366-372

  Hidalgo, Jorge ^a   Richards, Guy A ^b   Jiménez, Juan Ignacio Silesky ^c   Baker, Tim ^d,e   Amin, Pravin ^f  

^a Karl Heusner Memorial Hospital   (Belize)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c HOSPITAL SAN JUAN DE DIOS   (Costa Rica)

^d QUEEN ELIZABETH CENTRAL HOSPITAL   (Malawi)

^e KAROLINSKA INSTITUTE   (Sweden)

^f BOMBAY HOSPITAL   (India)

Author keywords

Crimean Congo hemorrhagic fever; Dengue; Hantavirus; Kyasanur Forest disease; Lassa fever; Marburgvirus and Ebolavirus; Rift Valley fever; Viral hemorrhagic fevers (VHF); Yellow fever; Zika

Indexed keywords

RIBAVIRIN;

AMERICAN HEMORRHAGIC FEVER; AUTOPSY; BLOOD VESSEL PERMEABILITY; CRIMEAN CONGO HEMORRHAGIC FEVER; DENGUE HEMORRHAGIC FEVER; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; EBOLA HEMORRHAGIC FEVER; ENZYME LINKED IMMUNOSORBENT ASSAY; HANTAVIRUS PULMONARY SYNDROME; HEALTH CARE PERSONNEL; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMAN; INCUBATION TIME; KYASANUR FOREST DISEASE; LASSA FEVER; MARBURG HEMORRHAGIC FEVER; MORTALITY; NEEDLE BIOPSY; NONHUMAN; PRACTICE GUIDELINE; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; RIFT VALLEY FEVER; RISK FACTOR; WEST NILE FEVER; YELLOW FEVER; ADVISORY COMMITTEE; DEVELOPING COUNTRY; DISEASE CARRIER; ECONOMICS; HEALTH CARE PLANNING; INTENSIVE CARE; INTENSIVE CARE UNIT; MEDICAL SOCIETY; OUTCOME ASSESSMENT; STANDARDS; TROPICAL MEDICINE; VIROLOGY; VIRUS HEMORRHAGIC FEVER;

ADVISORY COMMITTEES; CRITICAL CARE; DEVELOPING COUNTRIES; DISEASE RESERVOIRS; HEMORRHAGIC FEVERS, VIRAL; HUMANS; INTENSIVE CARE UNITS; MEDICALLY UNDERSERVED AREA; OUTCOME ASSESSMENT (HEALTH CARE); SOCIETIES, MEDICAL; TROPICAL MEDICINE;

EID: 85033405529     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2017.11.006     Document Type: Review

References (52)

1. Parola, P., Raoult, D., Ticks and tickborne bacterial diseases in humans: an emerging infectious threat. Clin Infect Dis 32:6 (2001), 897–928.
2. Leroy, E.M., Kumulungui, B., Pourrut, X., Rouquet, P., Hassanin, A., Yaba, P., et al. Fruit bats as reservoirs of Ebola virus. Nature 438:7068 (2005), 575–576.
3. Kilinc, C., Guckan, R., Capraz, M., Varol, K., Zengin, E., Mengeloglu, Z., et al. Examination of the specific clinical symptoms and laboratory findings of Crimean-Congo hemorrhagic fever. J Vector Borne Dis 53:2 (2016), 162–167.
4. Cikman, A., Aydin, M., Gulhan, B., Karakecili, F., Kesik, O.A., Ozcicek, A., et al. Seroprevalence of Crimean-Congo hemorrhagic fever virus in Erzincan Province, Turkey, relationship with geographic features and risk factors. Vector Borne Zoonotic Dis 16:3 (2016), 199–204.
5. Ibekwe, T.S., Nwegbu, M.M., Asogun, D., Adomeh, D.I., Okokhere, P.O., The sensitivity and specificity of Lassa virus IgM by ELISA as screening tool at early phase of Lassa fever infection. Niger Med J 53:4 (2012), 196–199.
6. Jeffs, B., A clinical guide to viral haemorrhagic fevers: Ebola, Marburg and Lassa. Trop Doct 36:1 (2006), 1–4.
7. Papa, A., Karabaxoglou, D., Kansouzidou, A., Acute West Nile virus neuroinvasive infections: cross-reactivity with dengue virus and tick-borne encephalitis virus. J Med Virol 83:10 (2011), 1861–1865.
8. Blow, J.A., Dohm, D.J., Negley, D.L., Mores, C.N., Virus inactivation by nucleic acid extraction reagents. J Virol Methods 119:2 (2004), 195–198.
9. Gire, S.K., Goba, A., Andersen, K.G., Sealfon, R.S., Park, D.J., Kanneh, L., et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 345:6202 (2014), 1369–1372.
10. Towner, J.S., Rollin, P.E., Bausch, D.G., Sanchez, A., Crary, S.M., Vincent, M., et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 78:8 (2004), 4330–4341.
11. Escadafal, C., Faye, O., Sall, A.A., Faye, O., Weidmann, M., Strohmeier, O., et al. Rapid molecular assays for the detection of yellow fever virus in low-resource settings. PLoS Negl Trop Dis, 8(3), 2014, e2730.
12. Drosten, C., Gottig, S., Schilling, S., Asper, M., Panning, M., Schmitz, H., et al. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol 40:7 (2002), 2323–2330.
13. Leski, T.A., Lin, B., Malanoski, A.P., Wang, Z., Long, N.C., Meador, C.E., et al. Testing and validation of high density resequencing microarray for broad range biothreat agents detection. PLoS One, 4(8), 2009, e6569.
14. Racsa, L.D., Kraft, C.S., Olinger, G.G., Hensley, L.E., Viral hemorrhagic fever diagnostics. Clin Infect Dis 62:2 (2016), 214–219.
15. Zaki, S.R., Shieh, W.J., Greer, P.W., Goldsmith, C.S., Ferebee, T., Katshitshi, J., et al. A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 179:Suppl. 1 (1999), S36–47.
16. Jentes, E.S., Robinson, J., Johnson, B.W., Conde, I., Sakouvougui, Y., Iverson, J., et al. Acute arboviral infections in Guinea, West Africa, 2006. Am J Trop Med Hyg 83:2 (2010), 388–394.
17. Meltzer, E., Arboviruses and viral hemorrhagic fevers (VHF). Infect Dis Clin North Am 26:2 (2012), 479–496.
18. Zumla, A., Ustianowski, A., Tropical diseases: definition, geographic distribution, transmission, and classification. Infect Dis Clin North Am 26:2 (2012), 195–205.
19. CDC, Guidance on personal protective equipment (PPE) to be used by healthcare workers during management of patients with confirmed ebola or persons under investigation (PUIs) for Ebola who are clinically unstable or have bleeding, vomiting, or diarrhea in U.S. hospitals, including procedures for donning and doffing PPE. https://wwwcdcgov/vhf/ebola/healthcare-us/ppe/guidancehtml, August 27 2015. (Accessed 16 May 2017)
20. Petersen, L.R., Hayes, E.B., West Nile virus in the Americas. Med Clin North Am 92:6 (2008), 1307–1322 [ix].
21. McCormick, J.B., King, I.J., Webb, P.A., Scribner, C.L., Craven, R.B., Johnson, K.M., et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med 314:1 (1986), 20–26.
22. Organisation WH, Lassa fever:Fact sheet. http://wwwwhoint/mediacentre/factsheets/fs179/en/, 2017.
23. Sprung, C.L., Zimmerman, J.L., Christian, M.D., Joynt, G.M., Hick, J.L., Taylor, B., et al. Recommendations for intensive care unit and hospital preparations for an influenza epidemic or mass disaster: summary report of the European Society of Intensive Care Medicine's task force for intensive care unit triage during an influenza epidemic or mass disaster. Intensive Care Med 36:3 (2010), 428–443.
24. Wernly, J.A., Dietl, C.A., Tabe, C.E., Pett, S.B., Crandall, C., Milligan, K., et al. Extracorporeal membrane oxygenation support improves survival of patients with Hantavirus cardiopulmonary syndrome refractory to medical treatment. Eur J Cardiothorac Surg 40:6 (2011), 1334–1340.
25. Bhatt, S., Gething, P.W., Brady, O.J., Messina, J.P., Farlow, A.W., Moyes, C.L., et al. The global distribution and burden of dengue. Nature 496:7446 (2013), 504–507.
26. Gubler, D.J., The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res 33:4 (2002), 330–342.
27. Groseth, A., Feldmann, H., Strong, J.E., The ecology of Ebola virus. Trends Microbiol 15:9 (2007), 408–416.
28. Barrette, R.W., Xu, L., Rowland, J.M., McIntosh, M.T., Current perspectives on the phylogeny of Filoviridae. Infect Genet Evol 11:7 (2011), 1514–1519.
29. Organisation, WH. Health worker Ebola infections in Guinea, Liberia and Sierra Leone. A preliminary report. http://wwwwhoint/hrh/documents/21may2015_web_finalpdf [May 21] 2015.
30. CDC. Chronology of marburg hemorrhagic fever outbreaks. https://wwwcdcgov/vhf/marburg/resources/outbreak-tablehtml. [December 3] 2014.
31. Towner, J.S., Pourrut, X., Albarino, C.G., Nkogue, C.N., Bird, B.H., Grard, G., et al. Marburg virus infection detected in a common African bat. PLoS One, 2(8), 2007, e764.
32. Rougeron, V., Feldmann, H., Grard, G., Becker, S., Leroy, E.M., Ebola and Marburg haemorrhagic fever. J Clin Virol 64 (2015), 111–119.
33. Hunt, L., Gupta-Wright, A., Simms, V., Tamba, F., Knott, V., Tamba, K., et al. Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study. Lancet Infect Dis 15:11 (2015), 1292–1299.
34. Organization. WH, Laboratory diagnosis of Ebola virus disease. 2014, World Health Organization, Geneva, Switzerland http://appswhoint/iris/bitstream/10665/134009/1/WHO_EVD_GUIDANCE_LAB_141_engpdf.
35. CDC, Guidance on Personal Protective Equipment (PPE) To Be Used By Healthcare Workers during Management of Patients with Confirmed Ebola or Persons under Investigation (PUIs) for Ebola who are Clinically Unstable or Have Bleeding, Vomiting, or Diarrhea in U.S. Hospitals. Including Procedures for Donning and Doffing PPE, August 27 2015 https://www.cdc.gov/vhf/ebola/healthcare-us/ppe/guidance.html. (Accessed 16 May 2017)
36. Hayden, F.G., Friede, M., Bausch, D.G., Experimental therapies for Ebola virus disease: what have we learned?. J Infect Dis 215:2 (2017), 167–170.
37. Henao-Restrepo, A.M., Longini, I.M., Egger, M., Dean, N.E., Edmunds, W.J., Camacho, A., et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet 386:9996 (2015), 857–866.
38. Evans, A., Gakuya, F., Paweska, J.T., Rostal, M., Akoolo, L., Van Vuren, P.J., et al. Prevalence of antibodies against Rift Valley fever virus in Kenyan wildlife. Epidemiol Infect 136:9 (2008), 1261–1269.
39. Al-Hazmi, M., Ayoola, E.A., Abdurahman, M., Banzal, S., Ashraf, J., El-Bushra, A., et al. Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans. Clin Infect Dis 36:3 (2003), 245–252.
40. Whitehouse, C.A., Crimean-Congo hemorrhagic fever. Antiviral Res 64:3 (2004), 145–160.
41. Ergonul, O., Crimean-Congo haemorrhagic fever. Lancet Infect Dis 6:4 (2006), 203–214.
42. Celikbas, A.K., Dokuzoguz, B., Baykam, N., Gok, S.E., Eroglu, M.N., Midilli, K., et al. Crimean-Congo hemorrhagic fever among health care workers, Turkey. Emerg Infect Dis 20:3 (2014), 477–479.
43. Ergonul, O., Celikbas, A., Baykam, N., Eren, S., Dokuzoguz, B., Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect 12:6 (2006), 551–554.
44. Ergonul, O., Evidence supports ribavirin use in Crimean-Congo hemorrhagic fever. Int J Infect Dis, 29, 2014, 296.
45. Leblebicioglu, H., Sunbul, M., Guner, R., Bodur, H., Bulut, C., Duygu, F., et al. Healthcare-associated Crimean-Congo haemorrhagic fever in Turkey, 2002–2014: a multicentre retrospective cross-sectional study. Clin Microbiol Infect, 22(4), 2016, 387 [e1-e4].
46. Charrel, R.N., de Lamballerie, X., Arenaviruses other than Lassa virus. Antiviral Res 57:1–2 (2003), 89–100.
47. Enria, D.A., Pinheiro, F., Rodent-borne emerging viral zoonosis. Hemorrhagic fevers and hantavirus infections in South America. Infect Dis Clin North Am 14:1 (2000), 167–184 [x].
48. Kilgore, P.E., Ksiazek, T.G., Rollin, P.E., Mills, J.N., Villagra, M.R., Montenegro, M.J., et al. Treatment of Bolivian hemorrhagic fever with intravenous ribavirin. Clin Infect Dis 24:4 (1997), 718–722.
49. Ghosh, S., Nagar, G., Problem of ticks and tick-borne diseases in India with special emphasis on progress in tick control research: a review. J Vector Borne Dis 51:4 (2014), 259–270.
50. Pavri, K., Clinical, clinicopathologic, and hematologic features of Kyasanur Forest disease. Rev Infect Dis 11:Suppl. 4 (1989), S854–9.
51. Holbrook, M.R., Kyasanur forest disease. Antiviral Res 96:3 (2012), 353–362.
52. Mourya, D.T., Sapkal, G.N., Yadav, P.D., Difference in vector ticks dropping rhythm governs the epidemiology of Crimean-Congo haemorrhagic fever & Kyasanur forest disease in India. Indian J Med Res 144:4 (2016), 633–635.